EGFR has been shown to display resistance against ionizing radiation in the following cancers: non-small-cell lung cancer [65,66,67,68], glioblastoma [69], breast cancer [70], head and neck squamous cell carcinoma [71], and colorectal cancer [72]. Here, EGFR is linked to colorectal cancer.